MediPharm Labs Corp.
MEDIF
$0.057
$0.00611.77%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.78M | -9.97M | -10.23M | -9.83M | -11.79M |
| Total Depreciation and Amortization | 2.03M | 2.11M | 2.09M | 1.86M | 1.74M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 628.80K | -500.10K | -3.93M | -5.27M | -3.49M |
| Change in Net Operating Assets | 4.42M | 4.73M | 4.01M | 4.05M | 3.15M |
| Cash from Operations | -1.71M | -3.63M | -8.06M | -9.19M | -10.39M |
| Capital Expenditure | -168.20K | -337.80K | -346.80K | -349.70K | -489.80K |
| Sale of Property, Plant, and Equipment | 551.10K | 1.97M | 1.95M | 1.55M | 1.42M |
| Cash Acquisitions | 0.00 | 0.00 | 754.10K | 754.10K | 754.10K |
| Divestitures | 3.12M | 3.12M | 3.12M | 3.12M | 4.43M |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.51M | 4.76M | 5.49M | 5.08M | 6.11M |
| Total Debt Issued | 799.00K | 749.00K | 1.07M | 1.07M | 1.07M |
| Total Debt Repaid | -3.11M | -1.20M | -1.87M | -2.01M | -2.16M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 462.00K | 531.00K | 1.28M | 576.00K | 565.00K |
| Cash from Financing | -1.35M | 51.60K | 363.10K | -267.40K | -384.30K |
| Foreign Exchange rate Adjustments | -337.50K | -279.10K | -231.10K | -240.00K | -194.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.60K | 896.10K | -2.45M | -4.62M | -4.86M |
